Search

Author/Creator Hock, K.

1. Anti‐OX40L alone or in combination with anti‐CD40L and CTLA4Ig does not inhibit the humoral and cellular response to a major grass pollen allergen. Issue 2 (February 2016)

Authors:
Gattringer, M.; Baranyi, U.; Pilat, N.; Hock, K.; Klaus, C.; Ramsey, H. E.; Wrba, F.; Valenta, R.; Wekerle, T.
Journal:
Clinical & experimental allergy
Issue:
Volume 46:Issue 2(2016:Feb.)
Page Start:
354
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Rapamycin and CTLA4Ig Synergize to Induce Stable Mixed Chimerism Without the Need for CD40 Blockade. Issue 6 (17th March 2015)

Authors:
Pilat, N.; Klaus, C.; Schwarz, C.; Hock, K.; Oberhuber, R.; Schwaiger, E.; Gattringer, M.; Ramsey, H.; Baranyi, U.; Zelger, B.; Brandacher, G.; Wrba, F.; Wekerle, T.
Journal:
American journal of transplantation
Issue:
Volume 15:Issue 6(2015:Jun.)
Page Start:
1568
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Resiliency among Older Adults Receiving Lung Cancer Treatment (ROAR-LCT, NCT04229381): The feasibility of a novel supportive care intervention with collection of longitudinal gut microbiome specimens and activity tracking during the COVID-19 Pandemic. (October 2022)

Authors:
Presley, C.; Grogan, M.; Hoyd, R.; Compston, A.; Hock, K.; Knauss, B.; Redder, E.; Arrato, N.; Lo, S.; Benedict, J.; Janse, S.; Hayes, S.; Williams, N.; Wheeler, C.; Carbone, D.; Paskett, E.; Andersen, B.; Spakowicz, D.
Journal:
Journal of geriatric oncology
Issue:
Volume 13(2022)Supplement 1
Page Start:
S32
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗